Eagle Pharmaceuticals Inc (EGRX)
0.7005
-0.05
(-6.60%)
USD |
OTCM |
Nov 14, 16:00
Eagle Pharmaceuticals Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -0.132M |
| March 31, 2023 | -33.57M |
| December 31, 2022 | 37.55M |
| September 30, 2022 | -13.24M |
| June 30, 2022 | 42.99M |
| March 31, 2022 | -16.78M |
| December 31, 2021 | 8.032M |
| September 30, 2021 | 1.062M |
| June 30, 2021 | 8.708M |
| March 31, 2021 | 10.09M |
| December 31, 2020 | 19.59M |
| September 30, 2020 | 5.426M |
| June 30, 2020 | 21.05M |
| March 31, 2020 | 2.686M |
| December 31, 2019 | -3.331M |
| September 30, 2019 | 10.31M |
| June 30, 2019 | 22.23M |
| March 31, 2019 | 26.00M |
| December 31, 2018 | 38.03M |
| September 30, 2018 | 3.655M |
| June 30, 2018 | 5.667M |
| March 31, 2018 | 4.902M |
| Date | Value |
|---|---|
| December 31, 2017 | 23.19M |
| September 30, 2017 | 6.314M |
| June 30, 2017 | 37.34M |
| March 31, 2017 | -13.11M |
| December 31, 2016 | 33.95M |
| September 30, 2016 | -1.011M |
| June 30, 2016 | -2.724M |
| March 31, 2016 | 2.304M |
| December 31, 2015 | -17.28M |
| September 30, 2015 | -7.706M |
| June 30, 2015 | -12.40M |
| March 31, 2015 | 25.79M |
| December 31, 2014 | -7.886M |
| September 30, 2014 | -7.135M |
| June 30, 2014 | -4.670M |
| March 31, 2014 | -2.099M |
| December 31, 2013 | 0.016M |
| September 30, 2013 | -0.3257M |
| June 30, 2013 | -2.763M |
| March 31, 2013 | -1.022M |
| December 31, 2012 | -1.809M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-33.57M
Minimum
Mar 2023
42.99M
Maximum
Jun 2022
6.009M
Average
5.426M
Median
Sep 2020
Free Cash Flow (Quarterly) Benchmarks
| Eli Lilly and Co | -458.90M |
| Verrica Pharmaceuticals Inc | -8.574M |
| NovaBay Pharmaceuticals Inc | -2.063M |
| Palatin Technologies Inc | -6.477M |
| iBio Inc | -4.854M |